glp-1 vs glp-1/gip Science Behind GLP 1 GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements TrimRX | GLP-1 vs GIP:

A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis

Dual-targeting approaches incorporating GLP-1R with co-receptors such as somatostatin receptor 2 (SSTR2), epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), or prostate-specific membrane antigen (PSMA) enhance target accessibility and therapeutic precision across heterogeneous lesions

When it comes to understanding your health, it can never be reduced to a single number, whether its BMI or the number on the scale

Dont like needles

The best available data show that both semaglutide and tirzepatide reduce fat mass substantially and lean mass to a lesser extent, roughly in proportion to total weight lost